Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU1-95P is a pseudogene that shares sequence similarity with genes encoding U1 small nuclear RNAs, essential non-coding RNAs involved in the major spliceosome complex responsible for intron removal from precursor mRNA during gene expression. Unlike canonical U1 snRNA genes, pseudogenes like RNU1-95P do not produce functional RNA molecules and have no known molecular function, disease association, or therapeutic relevance. They often arise via duplication or retrotransposition and accumulate mutations that render them inactive. In contrast, functional U1 snRNAs are central to pre-mRNA splicing, regulating transcriptome integrity and alternative splicing. There is no evidence that RNU1-95P participates in cellular activities or that it is relevant for disease or drug intervention.
None; not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 95, pseudogene (RNU1-95P).